Records containing: Hodgkin Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-09-16Phase I/IIA Study of the Novel Antifolate Agent Pralatrexate in Combination With the Histone Deacetylase Inhibitor Romidepsin for the Treatment of Patients With Peripheral T-cell Lymphoma
-
CLINICAL_TRIALS study results posted · 2026-09-01A Phase 2 Randomized Clinical Study of MK-4280A (Coformulated Favezelimab [MK-4280] Plus Pembrolizumab [MK-3475]) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (KEYFORM-008)
-
CLINICAL_TRIALS study results posted · 2026-06-30A Phase 2 Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma
-
CLINICAL_TRIALS study results posted · 2026-06-24A Phase I/II Clinical Trial of the Combination of Brentuximab Vedotin and Bendamustine in Patients With Relapsed or Refractory Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2026-04-27A Phase 2 Single Arm Study To Evaluate Safety And Preliminary Efficacy Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With Newly Diagnosed Early-Stage Non-Bulky Classical Hodgkin Lymphoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-24Methionine PET/CT Studies In Patients With Cancer
-
CLINICAL_TRIALS study record update · 2026-04-24Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
-
CLINICAL_TRIALS study record update · 2026-04-24Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2026-04-23A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer
-
CLINICAL_TRIALS study record update · 2026-04-23Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer
-
CLINICAL_TRIALS study record update · 2026-04-23Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
-
CLINICAL_TRIALS study record update · 2026-04-23Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2026-04-23BV-AVD in Patients With Newly-Diagnosed, Early Stage, Bulky Hodgkin Lymphoma Using a PET-adapted and MTV-guided Approach
-
CLINICAL_TRIALS study record update · 2026-04-23Familial Investigations of Childhood Cancer Predisposition
-
CLINICAL_TRIALS study record update · 2026-04-23Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2026-04-23Obstructive Sleep Apnea in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation
-
CLINICAL_TRIALS study record update · 2026-04-21A Modular Phase I/II, Open-label, Multicentre Study to Evaluate the Safety, Tolerability, and Efficacy of AZD3470, a PRMT5 Inhibitor, as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-20A Phase 1, Open-Label, Multiple-Ascending Dose Study of the Safety and Tolerability of CTX-8371 in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-20Expression of the Genome in Lymphoid Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase 1, Open Label, Dose Escalation, Dose Expansion, Multicenter, First in Human (FIH) Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of Oral AUR105 in Patients With Relapsed Advanced Malignancies (SURYA-1)
-
CLINICAL_TRIALS study record update · 2026-04-16Phase II Study of Second-line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2026-04-15Safety and Tolerability of Myeloablative Conditioning and Autologous Stem Cell Transplantation Followed by Polatuzumab Vedotin (PV) Immunoconjugate Therapy in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2026-04-15PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2026-04-14A Phase Ib/2 Trial of Fludarabine/Melphalan/Total Body Irradiation With Post Transplant Cyclophosphamide as Graft Versus Host Disease Prophylaxis in Matched-Related and Matched-Unrelated Allogeneic Hematopoietic Cell Transplantation
-
CLINICAL_TRIALS study record update · 2026-04-13A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications